Back to search

Peptide record

TPDB45810

Antiviral standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45810
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 16-aa standard natural antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
GLRCRLGRLLRRLGRC
Physicochemical Analysis
C78H148N34O17S2
ANDEQHIKMFPSTWYV
R
1898.37
12.40
6
0
5
+6
1.61
-0.263
121.88
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
6.58
2
Residue Composition
number
0
A
6
R
0
N
0
D
2
C
0
E
0
Q
3
G
0
H
0
I
5
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 3 H: 0 I: 0 L: 5 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
16
C78H148N34O17S2
1898.37
12.40
+6
1.61
-0.263
Evidence Records 2 records
Evidence 1 Activity

Activity

MIC
Antiviral
30 µM

Target

Escherichia coli

Source & Reference

DRAVP 2.0

Other

inhibited HSV-2MS in Vero cells (EC50 7.72 ug/ml) E. coli (MIC 30 uM) B. subtilis (MIC 60 uM).
Evidence 2 Activity

Activity

MIC
Antiviral
60 µM

Target

B. subtilis

Source & Reference

DRAVP 2.0

Other

inhibited HSV-2MS in Vero cells (EC50 7.72 ug/ml) E. coli (MIC 30 uM) B. subtilis (MIC 60 uM).